Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese.

Wang J, Yi L, Guo X, Liu M, Li H, Zou H, Gu Y, Tu W, Guo G, Yang L, Lai S, He D, Zhou X.

Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):635-8.

PMID:
25572744
2.

Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis/dermatomyositis in Chinese Han population.

Chen S, Wang Q, Wu Z, Li Y, Li P, Sun F, Zheng W, Wu Q, Wu C, Deng C, Zhang F, Li Y.

PLoS One. 2014 Oct 22;9(10):e110044. doi: 10.1371/journal.pone.0110044. eCollection 2014.

3.

IKKβ is an IRF5 kinase that instigates inflammation.

Ren J, Chen X, Chen ZJ.

Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17438-43. doi: 10.1073/pnas.1418516111. Epub 2014 Oct 17.

4.

Protein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells.

Lopez-Pelaez M, Lamont DJ, Peggie M, Shpiro N, Gray NS, Cohen P.

Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17432-7. doi: 10.1073/pnas.1418399111. Epub 2014 Oct 17.

5.

Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma.

Kreher S, Bouhlel MA, Cauchy P, Lamprecht B, Li S, Grau M, Hummel F, Köchert K, Anagnostopoulos I, Jöhrens K, Hummel M, Hiscott J, Wenzel SS, Lenz P, Schneider M, Küppers R, Scheidereit C, Giefing M, Siebert R, Rajewsky K, Lenz G, Cockerill PN, Janz M, Dörken B, Bonifer C, Mathas S.

Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4513-22. doi: 10.1073/pnas.1406985111. Epub 2014 Oct 6.

6.

IRF5rs2004640 single nucleotide polymorphism is associated with susceptibility to rheumatoid arthritis in South Indian Tamils.

Negi VS, Muralidharan N, Mehra S, Devaraju P, Mariaselvam CM, Gulati R, Salah S, Fortier C, Charron D, Krishnamoorthy R, Tamouza R.

Tissue Antigens. 2014 Nov;84(5):465-70. doi: 10.1111/tan.12441. Epub 2014 Oct 6.

PMID:
25284481
7.

Activation and function of interferon regulatory factor 5.

Ryzhakov G, Eames HL, Udalova IA.

J Interferon Cytokine Res. 2015 Feb;35(2):71-8. doi: 10.1089/jir.2014.0023. Epub 2014 Sep 26. Review.

PMID:
25259415
8.

Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses.

Chiba S, Ikushima H, Ueki H, Yanai H, Kimura Y, Hangai S, Nishio J, Negishi H, Tamura T, Saijo S, Iwakura Y, Taniguchi T.

Elife. 2014 Aug 22;3:e04177. doi: 10.7554/eLife.04177.

9.

Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population.

Santana-de Anda K, Gómez-Martín D, Monsivais-Urenda AE, Salgado-Bustamante M, González-Amaro R, Alcocer-Varela J.

Clin Exp Immunol. 2014 Dec;178(3):428-37. doi: 10.1111/cei.12429.

PMID:
25130328
10.

Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.

Tang L, Chen B, Ma B, Nie S.

Genet Mol Res. 2014 Jun 16;13(2):4473-85. doi: 10.4238/2014.June.16.6.

11.

Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis.

García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, Llorca J, González-Juanatey C, Corrales A, Ubilla B, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, Martín J, González-Gay MA.

Arthritis Res Ther. 2014 Jul 10;16(4):R146. doi: 10.1186/ar4608.

12.

Prediction of response to interferon therapy in multiple sclerosis.

Sellebjerg F, Søndergaard HB, Koch-Henriksen N, Sørensen PS, Oturai AB.

Acta Neurol Scand. 2014 Oct;130(4):268-75. doi: 10.1111/ane.12269. Epub 2014 Jun 18.

PMID:
24943672
13.

IRF5-mediated signaling and implications for SLE.

Lazzari E, Jefferies CA.

Clin Immunol. 2014 Aug;153(2):343-52. doi: 10.1016/j.clim.2014.06.001. Epub 2014 Jun 10. Review.

PMID:
24928322
14.

Genetic polymorphism of interferon regulatory factor 5 (IRF5) correlates with allograft acute rejection of liver transplantation.

Yu X, Wei B, Dai Y, Zhang M, Wu J, Xu X, Jiang G, Zheng S, Zhou L.

PLoS One. 2014 Apr 30;9(4):e94426. doi: 10.1371/journal.pone.0094426. eCollection 2014.

15.

Insight into gene polymorphisms involved in toll-like receptor/interferon signalling pathways for systemic lupus erythematosus in South East Asia.

Chai HC, Chua KH, Lim SK, Phipps ME.

J Immunol Res. 2014;2014:529167. doi: 10.1155/2014/529167. Epub 2014 Feb 17.

16.

Association of interferon regulatory factor 5 (IRF5) markers with an increased risk of lupus and overlapping autoimmunity in a Kuwaiti population.

AlFadhli S, Jahabani I.

Ann Hum Biol. 2014 Nov-Dec;41(6):531-9. doi: 10.3109/03014460.2014.899623. Epub 2014 Apr 3.

PMID:
24697591
17.

Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus.

Dang J, Shan S, Li J, Zhao H, Xin Q, Liu Y, Bian X, Liu Q.

Tissue Antigens. 2014 Jun;83(6):401-8. doi: 10.1111/tan.12349. Epub 2014 Apr 3.

PMID:
24697319
18.

Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells.

Yamashina T, Baghdadi M, Yoneda A, Kinoshita I, Suzu S, Dosaka-Akita H, Jinushi M.

Cancer Res. 2014 May 15;74(10):2698-709. doi: 10.1158/0008-5472.CAN-13-2169. Epub 2014 Mar 17.

19.

Lack of association of IRF5 gene polymorphisms with autoimmune thyroid disease: a case-control study. IRF5 gene and AITD.

Muhali FS, Zhou-jiao Z, Wang Y, Wang Q, Shi XH, Jiang WJ, Xiao L, Li DF, He ST, Xu J, Zhang JA.

Ann Endocrinol (Paris). 2014 Feb;75(1):19-24. doi: 10.1016/j.ando.2013.12.002. Epub 2014 Feb 26.

PMID:
24582590
20.

HIV-2 Vpx protein interacts with interferon regulatory factor 5 (IRF5) and inhibits its function.

Cheng X, Ratner L.

J Biol Chem. 2014 Mar 28;289(13):9146-57. doi: 10.1074/jbc.M113.534321. Epub 2014 Feb 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk